ISG’s commercial leadership experience spans the breadth of life sciences — therapeutic and medical device launches across nine clinical areas, from early-stage rare disease to global specialty pharma.
From early-stage biotech founders raising seed capital through global specialty pharma scaling commercial operations.
Senior commercial leadership for medical device innovators preparing for launch, expanding distribution, or building commercial infrastructure post-FDA clearance.
Commercial strategy and launch execution for diagnostic companies navigating reimbursement, channel strategy, and clinical adoption.
Active experience structuring in-licensing transactions, building commercial models, and supporting capital raises for specialty and rare disease companies.
Our consulting services are designed to help life sciences organizations develop strong commercial strategies, position their innovations effectively in the market, and accelerate sustainable growth.
.svg)
Supporting companies bringing innovative therapies, technologies, and healthcare solutions to market.
.svg)
Helping technology organizations scale growth, strengthen market positioning, and drive innovation.
.svg)
Advising financial institutions on strategy, operational performance, and market opportunities.
.svg)
Helping manufacturers improve operational efficiency and develop competitive strategies.
.svg)
Partnering with service-based organizations seeking to strengthen their strategic direction and growth.
ISG engages at the senior commercial layer — with the people whose decisions shape strategic direction.
For founders preparing for a capital raise, planning a commercial launch, or building the team to execute on both, ISG brings senior commercial experience that’s typically reserved for later-stage companies.
For Chief Commercial Officers, Chief Business Officers, and Chief Executive Officers, ISG provides senior advisory support, fractional executive bandwidth, and operational execution across portfolio strategy, commercial scale-up, and launch readiness.
For boards of directors, venture capital firms, and specialty life sciences investors, ISG provides commercial diligence, portfolio company support, and direct engagement with boards on commercial strategy and execution.
ISG engages on the strategic decisions that determine whether life sciences innovation translates into enterprise value. These are the moments where senior commercial experience compounds the value of every other decision in the room.
.png)
A selection of recent and current engagements illustrating how ISG works.
Medical device innovator. Led seed close, currently leading $10M convertible note bridge, engaging investors and aligning commercial strategy with funding milestones.
Canadian rare disease specialty pharma. Leading final stages of in-licensing negotiations for four specialty therapies, including diligence, term sheet development, and partnership structuring.
Scaled commercial organization, managed P&L exceeding $100M, supported and led multiple financing rounds while simultaneously executing first-in-class product launch.
Every engagement starts with a diagnostic conversation. Let’s define the inflection point and the leadership structure that fits the moment.
